BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Aileron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-19 5:21 pm Purchase |
2021-01-06 | 13G | Aileron Therapeutics, Inc. ALRN |
BIOTECHNOLOGY VALUE FUND L P | 263,278 6.300% |
263,278 (New Position) |
Filing |